Brokers said the beginning of new settlement in the derivatives segment also helped the index to end the day in the positive terrain.
The Sensex, which had lost 306.23 points in the past two sessions, recovered 37.25 points, or 0.15 per cent, to end at 25,099.92 during the session, it had touched the day's high of 25,209.61 at the outset.
Shares of Ranbaxy Laboratories caught buyers' fancy and jumped 5.14 per cent to close at Rs 496 per scrip after the company announced the US regulatory approval for hypertension drug to be launched by one of its subsidiaries.
On similar lines, the NSE index Nifty rose by 15.60 points, or 0.21 per cent, to end at 7,508.80 after moving between 7,538.75 and 7,482.30.
The sentiment got further boost with the rise in the rupee which was last trading higher at 60.11 against the US dollar.
Brokers further said market sentiments turned better on broad-based buying by funds and retail investors after crude oil prices in the global markets eased and beginning of new settlement of July series in the derivatives segment.
In the 30-scrip Sensex, 12 stocks gained, while 18 constituents ended lower.
Meanwhile, foreign portfolio investors (FPIs) sold shares worth a net Rs 601.89 crore yesterday, as per provisional data from the stock exchanges.
Sectorally, the BSE Healthcare sector index gained the most by rising 2.48 per cent, followed by IT (2.45 per cent), Teck (1.78 per cent) and Realty (0.80 per cent).
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
